Log in to save to my catalogue

Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differenti...

Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differenti...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2557533795

Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study

About this item

Full title

Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study

Publisher

Cham: Springer International Publishing

Journal title

Targeted oncology, 2021-09, Vol.16 (5), p.625-632

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Background
Renal cell carcinoma with sarcomatoid differentiation is a highly aggressive form of kidney cancer.
Objective
We aimed to analyze the outcomes of patients treated with cabozantinib for metastatic renal cell carcinoma with sarcomatoid features.
Methods
We retrospectively collected data from 16 worldwide centers. Overall sur...

Alternative Titles

Full title

Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2557533795

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2557533795

Other Identifiers

ISSN

1776-2596

E-ISSN

1776-260X

DOI

10.1007/s11523-021-00828-z

How to access this item